Author(s):
Tejas G. Jain, Amitkumar R. Dhankani, Mansi A. Dhankani, S. P. Pawar
Email(s):
Email ID Not Available
DOI:
10.52711/2231-5659.2024.00036 
Address:
Tejas G. Jain1*, Amitkumar R. Dhankani2, Mansi A. Dhankani2, S. P. Pawar2
1Department, M. Pharm (QA), P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India.
2Assistant Professor, Department of Pharmaceutical Quality Assurance, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada-425409, Maharashtra, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 3,
Year - 2024
ABSTRACT:
This research developed and validated a new, simple sensitive, suitable, economical, accurate, and robust ultra-high performance liquid chromatography (UHPLC) method for determining Alcaftadine in bulk drug and ophthalmic dosage formulation. The separation was performed using an HPLC method with a UV detector and Open lab EZchrome workstation program, Kromasil C18, 250mm X 4.6mm ID, 2.7µm Acetonitrile: 0.05% OPA (60:40%V/V) with a flow rate of 1.0mL/min and detected at 282nm. The developed UHPLC method yielded a suitable retention time for Alcaftadine of 2.20min, which was optimised using a trial-and-error basis. The linearity of the determined method was found a correlation coefficient (r2) of 0.9998 over the concentration range of 2.0-30.0µg/mL. The percentage RSD for the method's precision was found to be less than 2.0percent. The percentage recovery was discovered within the limit 0.259ug/mL and 0.784ug/mL were found to be the LOD and LOQ, respectively. The developed and validated UHPLC system takes less time and cheaply can be used in the industry for routine quality control/analysis of bulk drugs and marketed Alcaftadine products. In present studies, the retention time was less than previously reported. The developed method was validated in terms of specificity, linearity, accuracy, precision and robustness according to the ICH guidelines.
Cite this article:
Tejas G. Jain, Amitkumar R. Dhankani, Mansi A. Dhankani, S. P. Pawar. Method Development and Validation of Alcaftadine by UHPLC in Bulk and Dosage Form. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(3):221-6. doi: 10.52711/2231-5659.2024.00036
Cite(Electronic):
Tejas G. Jain, Amitkumar R. Dhankani, Mansi A. Dhankani, S. P. Pawar. Method Development and Validation of Alcaftadine by UHPLC in Bulk and Dosage Form. Asian Journal of Research in Pharmaceutical Sciences. 2024; 14(3):221-6. doi: 10.52711/2231-5659.2024.00036 Available on: https://ajpsonline.com/AbstractView.aspx?PID=2024-14-3-5
REFERENCES:
1. National PBM Drug Monograph (2015) Alcaftadine 0.25% Ophthalmic Solution (Lastacaft). VA Pharmacy Benefits Management Services. Medical Advisory Panel and VISN Pharmacist Executives.
2. Chemistry Review, http://www.accessdata.fda.gov/drugsatfda docs/nda/2010/022134s000ChemR.pdf. Accessed 16 Mar 2015)
3. https://go.drugbank.com/drugs/DB06766.
4. Clinical Pharmacology Review, http://www.fda.gov/downloads/Drugs/Developme nt Approval Process/Development Resources/UCM22 3817.pdf (last reviewed on 11th March 2015).
5. Bohets H, McGowan C, Mannens G, Schroeder N, Edwards-Swanson K, et al. Clinical pharmacology of alcaftadine, a novel antihistamine for the prevention of allergic conjunctivitis. J Ocul Pharmacol Ther. 2011; 27: 187-195.
6. Vidushi, Y., and Meenakshi, B. A review of HPLC method development and validation. Res J Life Sci, Bioinform, Pharm Chem Sci, 2017; 2(6): 178.
7. Nilesh S. Pendhbaje, Rupali V. Nirmal, Ashwini A. Jamdhade, Shain M. Pathan. Method Development and Validation by HPLC: A Brief Review. Research and Reviews: A Journal of Pharmaceutical Science. 2021; 12(1): 27–39p
8. Bose, A. HPLC calibration process parameters in terms of system suitability test. Austin Chromatography. 2014; 1(2): 14.
9. Sabir, A.M. HPLC method development and validation a review. International Research Journal of Pharmacy. 2013; 4(4): 39-46.
10. Pendbhaje N.S. Jamdhade A.A., Pathan S.M., Nirmal R.V. A Review on Quantification of Brexpiprazole in Its Bulk and Pharmaceutical Dosage Form by Various Analytical Methods. International Journal of Pharmaceutical Research and Applications. 2021; 6(1): 1118-1132.
11. Mishra, P. R., Satone, D., and Meshram, D. B. Development and validation of HPLC method for the determination of Alcaftadine in bulk drug and its ophthalmic solution. J Chromatogr Sep Tech. 2016; 7(312): 2.
12. Badr El-Din, K., Ahmed, A., Khorshed, A., Derayea, S., Oraby, M. Smart Spectrophotometric Methods Based on Feasible Mathematical Processing and Classical Chemometry for The Simultaneous Assay of Alcaftadine and Ketorolac in Their Recently Approved Pharmaceutical Formulation. Egyptian Journal of Chemistry. 2022; 65(2): 167-174. doi: 10.21608/ejchem.2021.82464.4098.